By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Eisai and Forma Therapeutics on Wednesday announced a collaboration for use of Forma's screening technology to support new drug development in Eisai's pipeline.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.